Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinics, 1st Edition
Authors :
John N van den Anker & Max J. Coppes & Gideon Koren
The need for safe and effective use of medicines in children and WHO's initiative "Make Medicines Child Size" have boosted research and educational activities in the area of pediatric clinical drug research. This issue focuses on both general and spe ...view more
The need for safe and effective use of medicines in children and WHO's initiative "Make Medicines Child Size" have boosted research and educational activities in the area of pediatric clinical drug research. This issue focuses on both general and specific aspects of neonatal and pediatric clinical pharmacology including ethics, pharmacogenomics, metabolomics, adverse drug reactions, pain medication, pulmonary hypertension and several other hot topics. The editors have been able to find outstanding authors for the different parts on neonatal and pediatric pharmacology.
The need for safe and effective use of medicines in children and WHO's initiative "Make Medicines Child Size" have boosted research and educational activities in the area of pediatric clinical drug research. This issue focuses on both general and specific aspects of neonatal and pediatric clinical pharmacology including ethics, pharmacogenomics, metabolomics, adverse drug reactions, pain medication, pulmonary hypertension and several other hot topics. The editors have been able to find outstanding authors for the different parts on neonatal and pediatric pharmacology.
Author Information
By John N van den Anker, MD, Professor of Pediatrics, Pharmacology and Physiology
GWU School of Medicine and Health Sciences, Washington, DC; Max J. Coppes, MD, PhD, MBA, Children's National Medical Center, Washington, DC and Gideon Koren, MD, Toronto, Canada
https://www.us.elsevierhealth.com/neonatal-and-pediatric-clinical-pharmacology-an-issue-of-pediatric-clinics-9781455749188.html6955Neonatal and Pediatric Clinical Pharmacology, An Issue of Pediatric Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781455749188_7.jpg64.3498.99USDInStock/Medicine/Pediatrics/Clinics/Clinics154388725525504113841826925145120The need for safe and effective use of medicines in children and WHO's initiative "Make Medicines Child Size" have boosted research and educational activities in the area of pediatric clinical drug research. This issue focuses on both general and specific aspects of neonatal and pediatric clinical pharmacology including ethics, pharmacogenomics, metabolomics, adverse drug reactions, pain medication, pulmonary hypertension and several other hot topics. The editors have been able to find outstanding authors for the different parts on neonatal and pediatric pharmacology. The need for safe and effective use of medicines in children and WHO's initiative "Make Medicines Child Size" have boosted research and educational activities in the area of pediatric clinical drug research. This issue focuses on both general and specific aspects of neonatal and pediatric clinical pharmacology including ethics, pharmacogenomics, metabolomics, adverse drug reactions, pain medication, pulmonary hypertension and several other hot topics. The editors have been able to find outstanding authors for the different parts on neonatal and pediatric pharmacology.00add-to-cart97814557491882012ProfessionalBy John N van den Anker, MD, Max J. Coppes, MD, PhD, MBA and Gideon Koren, MD20121BookOtherSaunders240Oct 8, 2012IN STOCK - This may take up to 5 business days to shipBy <STRONG>John N van den Anker</STRONG>, MD, Professor of Pediatrics, Pharmacology and Physiology
GWU School of Medicine and Health Sciences, Washington, DC; <STRONG>Max J. Coppes</STRONG>, MD, PhD, MBA, Children's National Medical Center, Washington, DC and <STRONG>Gideon Koren</STRONG>, MD, Toronto, CanadaClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
